The European Union's drug regulator has recommended approval of Moderna's updated formulation of COVID-19 shot Spikevax, the ...

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

If you're confident that its current trials will prove successful, then this is one to buy and sit on. One word of caution ...

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents, in the latest round of a ...

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA ...

How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization (EUA) since 2022. That meant that, theoretically, all children had access to ...

Moderna stock rises on flu vaccine data and FDA approvals, while healthcare stocks remain under pressure amid political ...

A COVID-19 vaccine developed by Moderna and the National Institutes of Health has become the second to receive emergency-use authorization from the Food and Drug Administration.

Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it, the company announced Wednesday.

Moderna’s Covid Vaccine: What You Need to Know. By Carl Zimmer and Denise Grady. Published Nov. 16, 2020 Updated Nov. 30, 2020. Share full article. Image.

A second coronavirus vaccine has now joined the fight against COVID-19 in the United States. On December 18, the U.S. Food and Drug Administration authorized Moderna’s vaccine for emergency use ...